Advances in Exposure With Response Prevention
In his zeal for ERP, Abramowitz enthuses that deriving treatment from experimental research remains unique, in the field of mental health, to behaviourally oriented therapies. 1 However, is it possible that the treatment has become rather ossified precisely because behavioural therapists have neglected experimental research, particularly that from neuroscience?
Rudi De Raedt's useful recent review of neuroimaging research 2 confirms the importance of the neurocircuitry of emotion processing for understanding the actual working mechanisms of exposure therapy. The important implication for developing ERP techniques is that, during exposure therapy, it would be best to fully direct the focus of attention toward the emotional content of the threatening situation. This appears to facilitate prefrontal control over the amygdala. 2 De Raedt points out that the contribution of neuroscience to modifying exposure approaches is currently crucial, with the recent suggestion that propositionally learned fear (such as talking about the threatening value of a stimulus) depends more on the left amygdala, whereas experientially learned fear (being confronted with the object of fear) is more strongly associated with the right amygdala. 2 The right amygdala demonstrates more rapid habituation to fearful stimuli, compared with the left amygdala, and this has obvious and dramatic implications for exposure therapy. It would appear that cognitively conscious controlled ("top-down") processing is related to the left amygdala, whereas experienced, sensory driven ("bottom-up") processing is related to the right amygdala. 3 This, at last, helps to explain why knowing at a rational, conscious level that something poses no danger frequently does little to reduce emotional reactions to the stimulus. 2 These and other recent neuroscience findings suggest that ERP and other exposure approaches would be enhanced by a full experience of the emotional arousal.
Could it be that ERP and other techniques from the behaviourist and cognitive-behavioural therapy tradition continue to have only limited effectiveness precisely because traditional cognitive and behavioural therapists talk about emotions in a particular detached and cognitive manner? Perhaps, in doing so, they inadvertently discourage patients from actually experiencing emotion in therapy. A required modification of ERP and other exposure approaches could be to encourage patients to experience and understand aroused emotional states with the aim of learning to control them.
There is something deliciously ironic in the fact that, despite their historical dismissal of psychodynamically oriented approaches, psychiatrists, via neuroscience, could be about to perform yet another about-face and bring back catharsis, or emotional release, albeit in some heavily modified form. After all, catharsis was where the whole psychodynamic adventure began! Raj Persaud, FRCPsych London, England
Clinical Practice Guidelines for Anxiety Disorders
Dear Editor:
The Canadian Clinical Practice Guidelines: Management of Anxiety Disorders 1 is an important and useful document. Nevertheless, it appears to contain a couple of errors. For example, it states 1, p 25S that applied relaxation is not recommended in the management of panic disorder. Three sources are given to support that position. However, one of these is a review that concludes "this may be a useful treatment," 2 another is a study comparing relaxation, exposure, and cognitive therapy that concludes "they are about equally effective," 3 and the last is a study comparing relaxation and cognitive-behavioural therapy that concludes "both . . . are effective treatments of panic disorder." 4 A more recent review 5 also finds in favour of relaxation therapy.
The Guidelines state p 20S that the Depression Anxiety Stress Scale is available free of charge from a University of New South Wales website. Although it is true that the sheet the patient marks is free, the manual to make sense of these marks is only available on payment of hefty AU$50.00.
Saxby Pridmore MD, AM Tasmania, Australia

Reply: Clinical Practice Guidelines for Anxiety Disorders
We thank Dr Pridmore for his helpful comments on the Canadian Clinical Practice Guidelines: Management of Anxiety Disorders. 1 As he points out, it is clear that promising studies indicate that applied relaxation (AR) is helpful in the treatment of panic disorder (and also for generalized anxiety disorder). In several of these studies, AR is found to be as effective as more widely evaluated forms of cognitive-behavioural therapy (CBT). We described it as not recommended for panic disorder, not to indicate that it is ineffective but, rather, because the reviewers felt that there is less research to support this technique, compared with research for other widely used techniques. The well-designed studies showing equivalent results for AR and CBT with panic disorder were carried out by the originator of the procedure, Dr Öst. 2,3 Studies by Clark et al in 1994 4 found AR to be helpful but not as effective as CBT.
Öst, in comparing the studies, 3 indicated that Clark's group had more experience with CBT, whereas the Öst group had more experience with AR. He also suggests that modest changes in the procedure (such as having the participants apply the techniques in anxiety-arousing situations earlier in the Clark study than in the Öst studies) possibly had an impact on the different findings from the different studies.
The AR procedure developed by Öst, including progressive muscle relaxation, is not identical to the relaxation procedures familiar to many clinicians. More traditional relaxation procedures do not have the support for their effectiveness that exists for AR. The AR procedure has been described in detail by Öst 5 and is taught and applied over 12 treatment sessions; in these sessions, the procedures are learned and applied at a specific pace. Instructions for sessions 8 and 9 suggest, as homework, applying the procedures in stressful but nonpanic situations, and instructions for the last 2 or 3 sessions encourage the application of the procedures in a wider range of stressful situations. Clearly, this homework has some elements of exposure to feared situations. In a recent review of muscle relaxation treatments, Conrad and Roth 6 summarize the promising results for effectiveness and call for more research on mechanisms of action (which may or may not be related to muscle tension). These authors point out that AR and similar procedures have the advantage of being well accepted by patients and that they may be easier to teach to clinicians and patients than more complex CBT procedures.
Given the limited research on AR and its limited application internationally to date, we would argue that support for this approach is not as strong as for some of the other treatments. Conversely, our description of it as a "not recommended treatment" may be too strong. With regard to generalized anxiety disorder, the research for the use of AR is broader, and we do not list it as "not recommended" treatment in that section of the Guidelines. Our comment in the generalized anxiety disorder section may be particularly relevant in regard to this issue:
In clinical practice, as opposed to clinical trials, experienced therapists develop interventions focused on the case formulation and the approach is individualized to the problems experienced by the patient. 1 
